期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 532, 期 1-2, 页码 178-186出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2006.01.005
关键词
2 ',4 ',6 '-tris(methoxymethoxy) chalcone; nitric oxide; nuclear factor-kappa B; heme oxygenase 1; p42/44 MAPK; GSH
We report that the synthetic chalcone 2',4',6'-tris(methoxymethoxy) chalcone (TMMC) is an anti-inflammatory compound that reduces nitric oxide (NO) production by inhibiting of inducible NO synthase (NOS) expression, and that TMMC decreases the degradation of the inhibitory factor kappa B, leading to inhibition of nuclear factor-kappa B translocation into the nucleus in lipopolysaccharide (LPS)-activated RAW 264.7 macrophages. We also demonstrate that TMMC by itself is a potent inducer of heme oxygenase I (HO-1). Inhibition of HO-1 activity or scavenging of carbon monoxide, a byproduct of heme degradation, significantly attenuated this anti-inflammatory action. Treating cells with the specific p42/44 MAPK inhibitor, PD98059, blocked the TMMC-mediated induction of HO-1 and the inhibition of LPS-stimulated expression of iNOS. TMMC also depleted intracellular GSH. Our data suggest that TMMC exerts an anti-inflammatory effect in macrophages through a mechanism that involves the induction of HO-1, which is mediated by activation of p42/44 MAPK and GSH depletion. (c) 2006 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据